Roper Technologies to acquire CentralReach
Roper Technologies (Nasdaq: ROP) has announced a definitive agreement to acquire CentralReach from Insight Partners for a net purchase price of $1.65 billion, including a $200 million tax benefit. CentralReach, a leading provider of cloud-native software for Applied Behavior Analysis (ABA) therapy, serves over 200,000 professionals providing care for individuals with autism spectrum disorder and related disabilities.
The acquisition target is expected to contribute $175 million in revenue and $75 million in EBITDA for the twelve months ending June 30, 2026. Roper anticipates CentralReach to achieve sustainable 20%+ organic revenue and EBITDA growth. The transaction, set to close in April/May 2025, will be funded through Roper's revolving credit facility and will be reported in Roper's Application Software segment.
Roper Technologies (Nasdaq: ROP) ha annunciato un accordo definitivo per acquisire CentralReach da Insight Partners per un prezzo netto di acquisto di 1,65 miliardi di dollari, inclusi 200 milioni di dollari di benefici fiscali. CentralReach, un fornitore leader di software nativo cloud per la terapia di Analisi Comportamentale Applicata (ABA), serve oltre 200.000 professionisti che forniscono assistenza a individui con disturbo dello spettro autistico e disabilità correlate.
Si prevede che l'obiettivo di acquisizione contribuirà con 175 milioni di dollari di fatturato e 75 milioni di dollari di EBITDA per i dodici mesi che si concludono il 30 giugno 2026. Roper prevede che CentralReach raggiunga una crescita sostenibile del 20%+ in fatturato ed EBITDA organico. La transazione, che dovrebbe chiudersi ad aprile/maggio 2025, sarà finanziata attraverso la linea di credito revolving di Roper e sarà riportata nel segmento Software Applicativo di Roper.
Roper Technologies (Nasdaq: ROP) ha anunciado un acuerdo definitivo para adquirir CentralReach de Insight Partners por un precio neto de compra de 1.65 mil millones de dólares, incluyendo un beneficio fiscal de 200 millones de dólares. CentralReach, un proveedor líder de software nativo en la nube para la terapia de Análisis de Comportamiento Aplicado (ABA), atiende a más de 200,000 profesionales que brindan atención a individuos con trastorno del espectro autista y discapacidades relacionadas.
Se espera que el objetivo de adquisición contribuya con 175 millones de dólares en ingresos y 75 millones de dólares en EBITDA durante los doce meses que finalizan el 30 de junio de 2026. Roper anticipa que CentralReach logrará un crecimiento sostenible de más del 20% en ingresos y EBITDA orgánicos. La transacción, que se espera cerrar en abril/mayo de 2025, se financiará a través de la línea de crédito rotativa de Roper y se informará en el segmento de Software de Aplicación de Roper.
로퍼 테크놀로지스 (Nasdaq: ROP)는 인사이트 파트너스로부터 센트럴리치를 인수하기 위한 최종 계약을 발표했습니다. 순 매입 가격은 16억 5천만 달러이며, 여기에는 2억 달러의 세금 혜택이 포함됩니다. 센트럴리치는 응용 행동 분석(ABA) 치료를 위한 클라우드 네이티브 소프트웨어의 선도적인 제공업체로, 자폐 스펙트럼 장애 및 관련 장애인을 돌보는 20만 명 이상의 전문가에게 서비스를 제공합니다.
인수 대상은 2026년 6월 30일로 종료되는 12개월 동안 1억 7천5백만 달러의 수익과 7천5백만 달러의 EBITDA에 기여할 것으로 예상됩니다. 로퍼는 센트럴리치가 지속 가능한 20% 이상의 유기적 수익 및 EBITDA 성장을 달성할 것으로 기대하고 있습니다. 이 거래는 2025년 4월/5월에 마감될 예정이며, 로퍼의 회전 신용 시설을 통해 자금이 지원되고 로퍼의 응용 소프트웨어 부문에 보고될 것입니다.
Roper Technologies (Nasdaq: ROP) a annoncé un accord définitif pour acquérir CentralReach d'Insight Partners pour un prix d'achat net de 1,65 milliard de dollars, y compris un avantage fiscal de 200 millions de dollars. CentralReach, un fournisseur de premier plan de logiciels natifs cloud pour la thérapie d'analyse comportementale appliquée (ABA), sert plus de 200 000 professionnels fournissant des soins aux personnes atteintes de troubles du spectre autistique et de handicaps connexes.
L'objectif d'acquisition devrait contribuer 175 millions de dollars de revenus et 75 millions de dollars d'EBITDA pour les douze mois se terminant le 30 juin 2026. Roper prévoit que CentralReach atteindra une croissance organique de plus de 20% en revenus et EBITDA durable. La transaction, qui devrait être finalisée en avril/mai 2025, sera financée par la facilité de crédit renouvelable de Roper et sera rapportée dans le segment logiciel d'application de Roper.
Roper Technologies (Nasdaq: ROP) hat eine endgültige Vereinbarung zur Übernahme von CentralReach von Insight Partners zu einem Nettokaufpreis von 1,65 Milliarden US-Dollar bekannt gegeben, einschließlich eines Steuerbenefits von 200 Millionen US-Dollar. CentralReach, ein führender Anbieter von cloud-nativer Software für die angewandte Verhaltensanalyse (ABA), bedient über 200.000 Fachleute, die Betreuung für Personen mit Autismus-Spektrum-Störung und verwandten Behinderungen anbieten.
Das Übernahmeziel wird voraussichtlich 175 Millionen US-Dollar Umsatz und 75 Millionen US-Dollar EBITDA für die zwölf Monate bis zum 30. Juni 2026 beitragen. Roper erwartet, dass CentralReach ein nachhaltiges Wachstum von über 20% bei organischen Umsätzen und EBITDA erzielen wird. Die Transaktion, die voraussichtlich im April/Mai 2025 abgeschlossen wird, wird über die revolvierende Kreditfazilität von Roper finanziert und im Anwendungssoftware-Segment von Roper ausgewiesen.
- Net purchase price includes $200M tax benefit, improving deal economics
- Expected high growth with 20%+ organic revenue and EBITDA expansion
- Strong recurring revenue model with high customer retention
- Immediately accretive with $175M revenue and $75M EBITDA contribution
- Market leadership in specialized ABA therapy software niche
- Significant leverage required with funding through revolving credit facility
- Large acquisition price of $1.65B could strain financial resources
- Regulatory approval still pending, creating closing uncertainty
Insights
Roper's $1.65 billion acquisition of CentralReach represents a strategic expansion into a high-growth healthcare SaaS niche with excellent financial characteristics. The deal values CentralReach at approximately 9.4x forward EBITDA based on the projected
What stands out is CentralReach's exceptional EBITDA margin of
The financing through Roper's revolving credit facility suggests management's confidence in their balance sheet flexibility and the cash-generating potential of this acquisition. The
This acquisition perfectly aligns with Roper's disciplined capital allocation strategy of acquiring niche market leaders with mission-critical solutions and strong customer retention. Moreover, the
CentralReach represents an exceptional technological fit within Roper's portfolio, operating in the highly specialized Applied Behavior Analysis (ABA) therapy software market. Their platform functions as the mission-critical operating system for therapy providers, creating significant switching costs and customer lock-in.
The comprehensive nature of CentralReach's solution—combining electronic medical records with practice management, scheduling, clinical data collection, and AI-powered modules—creates a complete ecosystem that addresses the unique workflow requirements of ABA therapy providers. This specialized focus has allowed them to build purpose-built tools that generic healthcare software platforms cannot easily replicate.
With 200,000 professionals using the platform, CentralReach has established significant market penetration in this specialized niche. The cloud-native architecture provides scalability advantages and enables continuous feature deployment, supporting the projected
The AI-powered modules mentioned represent a key differentiation and growth vector, as algorithmic assistance in therapy planning and outcome measurement can significantly enhance practitioner efficiency while improving care quality. This technology moat, combined with the specialized nature of ABA therapy workflows, creates sustainable competitive advantages that justify premium pricing and explain the exceptional margin profile.
Under Roper's ownership model—which typically preserves operational independence while providing capital for growth—CentralReach should maintain its innovation velocity while potentially accelerating market penetration through enhanced go-to-market resources.
Leading provider of SaaS solutions for Applied Behavior Analysis therapy
SARASOTA, Fla., March 24, 2025 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) today announced that it has reached a definitive agreement to acquire CentralReach from Insight Partners for a net purchase price of approximately
CentralReach is a leading provider of cloud-native software enabling the workflow and administration of Applied Behavior Analysis (“ABA”) therapy. Over 200,000 professionals utilize CentralReach’s purpose-built solutions to help provide care for individuals with autism spectrum disorder (“ASD”) and related intellectual and developmental disabilities (“IDD”). ABA therapy providers rely on CentralReach’s comprehensive electronic medical records platform as their mission critical operating system, which includes highly specialized tools for client set-up, practice management, claims processing, care scheduling, clinical data collection, and service delivery, along with several AI-powered add-on modules.
“CentralReach is a fantastic business with clear niche market leadership, mission critical and high ROI solutions, a high recurring revenue mix, and outstanding customer retention, which leads to strong organic revenue growth and excellent cash conversion,” said Neil Hunn, Roper’s President and CEO. “This acquisition is another example of Roper identifying a business that provides greater value creation for our shareholders. CentralReach meets each of our long-standing acquisition criteria, while also having a structurally faster organic growth profile and the ability to expand margins under Roper’s long-term ownership. We are excited to welcome the CentralReach team to the Roper family and look forward to partnering with the team to execute their strategy.”
Acquisition financial outlook and financing
CentralReach is expected to contribute approximately
The transaction is expected to close in April/May 2025, subject to regulatory approval and customary closing conditions, and will be funded using Roper’s revolving credit facility. Additional information about CentralReach is available in the Investors section of Roper’s website (www.ropertech.com).
Use of non-GAAP financial information
Roper supplements its consolidated financial statements presented on a GAAP basis with certain non-GAAP financial information, including EBITDA, to provide investors with greater insight, increase transparency and allow for a more comprehensive understanding of the information used by management in its financial and operational decision-making. Roper defines EBITDA as earnings before interest, taxes, depreciation, and amortization. Roper has not provided a reconciliation of the expected EBITDA contribution by CentralReach to the expected net income contribution by CentralReach for the twelve months ending June 30, 2026 because we are unable to quantify certain amounts that would be required to be included in CentralReach’s contribution to net income without unreasonable efforts. In addition, Roper believes such reconciliation would imply a degree of precision that would be confusing or misleading to investors. The non-GAAP financial measure disclosed by Roper in this press release should not be considered a substitute for, or superior to, financial measures prepared in accordance with GAAP, and the financial results prepared in accordance with GAAP and reconciliations from these results should be carefully evaluated.
About Roper Technologies
Roper Technologies is a constituent of the Nasdaq 100, S&P 500, and Fortune 1000. Roper has a proven, long-term track record of compounding cash flow and shareholder value. The Company operates market leading businesses that design and develop vertical software and technology enabled products for a variety of defensible niche markets. Roper utilizes a disciplined, analytical, and process-driven approach to redeploy its excess capital toward high-quality acquisitions. Additional information about Roper is available on the Company’s website at www.ropertech.com.
About CentralReach
CentralReach is a leading provider of Autism and IDD Care Software, providing a complete, end-to-end software and services platform that helps therapists who serve children and adults diagnosed with autism spectrum disorder (ASD) and related intellectual and developmental disabilities (IDD). With its roots in Applied Behavior Analysis, the company is revolutionizing how the lifelong journey of autism and IDD care is enabled at home, school, and work with powerful and intuitive solutions purpose-built for each care setting.
Trusted by more than 200,000 professionals globally, CentralReach is committed to ongoing product advancement, market-leading industry expertise, world-class client satisfaction, and support of the autism and IDD community to propel autism and IDD care into a new era of excellence. For more information, please visit www.CentralReach.com.
Contact information:
Investor Relations
941-556-2601
investor-relations@ropertech.com
The information provided in this press release contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements may include, among others, statements regarding operating results, the success of our internal operating plans, and the prospects for newly acquired businesses to be integrated and contribute to future growth, profit and cash flow expectations. Forward-looking statements may be indicated by words or phrases such as "anticipate," "estimate," "plans," "expects," "projects," "should," "will," "believes," "intends" and similar words and phrases. These statements reflect management's current beliefs and are not guarantees of future performance. They involve risks and uncertainties that could cause actual results to differ materially from those contained in any forward-looking statement. Such risks and uncertainties include our ability to identify and complete acquisitions consistent with our business strategies, integrate acquisitions that have been completed, realize expected benefits and synergies from, and manage other risks associated with, acquired businesses, including obtaining any required regulatory approvals with respect thereto. We also face other general risks, including our ability to realize cost savings from our operating initiatives, general economic conditions and the conditions of the specific markets in which we operate, including risks related to labor shortages and rising interest rates, changes in foreign exchange rates, risks related to changing U.S. and foreign trade policies, including increased trade restrictions or tariffs, risks associated with our international operations, cybersecurity and data privacy risks, including litigation resulting therefrom, risks related to political instability, armed hostilities, incidents of terrorism, public health crises (such as the COVID-19 pandemic) or natural disasters, increased product liability and insurance costs, increased warranty exposure, future competition, changes in the supply of, or price for, parts and components, including as a result of inflation and potential supply chain constraints, environmental compliance costs and liabilities, risks and cost associated with litigation, potential write-offs of our substantial intangible assets, and risks associated with obtaining governmental approvals and maintaining regulatory compliance for new and existing products. Important risks may be discussed in current and subsequent filings with the SEC. You should not place undue reliance on any forward-looking statements. These statements speak only as of the date they are made, and we undertake no obligation to update publicly any of them in light of new information or future events.
FAQ
What is the acquisition price for CentralReach by Roper Technologies (ROP)?
What are the expected revenue and EBITDA contributions from CentralReach to ROP?
When will Roper Technologies (ROP) complete the CentralReach acquisition?
What is the projected growth rate for CentralReach under ROP ownership?
How many professionals currently use CentralReach's platform?
